Suppression of TSH in congenital hypothyroidism is significantly related to serum levels and dosage of thyroxine

Hormone Research

Volumn 59, Issue 2, 2003, Pages 85-90

  Brown, J J ^a   Datta, V ^a   Sutton, A J ^b   Swift, P G F ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Congenital hypothyroidism, infants; Thyrotropin suppression; Thyroxine serum levels

Indexed keywords

THYROTROPIN; THYROXINE;

ARTICLE; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

AGING; CONGENITAL HYPOTHYROIDISM; FEMALE; HUMANS; HYPOTHYROIDISM; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; RETROSPECTIVE STUDIES; THYROTROPIN; THYROXINE;

EID: 0037279279     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068576     Document Type: Article

References (30)

1. New England Congenital Hypothyroidism Collaborative: Characteristics of infantile hypothyroidism discovered on neonatal screening. J Pediatr 1984;104:539-544.
2. Derksen-Lubsen G, Verkerk PH: Neuropsychologic development in early treated congenital hypothyroidism: Analysis of literature data. Pediatr Res 1996;39:561-566.
3. Grant DB: Congenital hypothyroidism: Optimal management in the light of 15 years' experience of screening. Arch Dis Child 1995;72:85-89.
4. Van Vliet G: Neonatal hypothyroidism: Treatment and outcome. Thyroid 1999;9:79-84.
5. Hindmarsh PC: Optimisation of thyroxine dose in congenital hypothyroidism. Arch Dis Child 2002;86:73-75.
6. Dubuis JM, Glorieux J, Richer F, Deal CL, Dussault JH, Van Vliet G: Outcome of severe congenital hypothyroidism: Closing the developmental gap with early high dose thyroxine treatment. J Clin Endocrinol Metab 1996;81: 222-227.
7. Bongers-Shokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama S: Influence of timing of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000;136:292-297.
8. Raza J, Hindmarsh PC, Brook CG: Factors involved in the rate of fall of thyroid stimulating hormone in treated hypothyroidism. Arch Dis Child 1997;77:526-527.
9. Abusrewil SS, Tyfield L, Savage DC: Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism. Arch Dis Child 1988;63:1368-1371.
10. Walker P, Dussault JH: Long-term effects of neonatal thyroid dysfunction in the rat: Implication for neonatal screening; in Dussault JH, Walker P (eds): Congenital Hypothyroidism. New York, Dekker, 1983, pp 397-410.
11. Nicoloff JT, Spencer CA: Clinical Review 12: The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 1990;71:553-558.
12. Touati G, Leger J, Toublanc JE, Farriaux JP, Stuckens C, Ponte C, David M, Rochiccoli P, Porquet D, Czernichow P: A thyroxine dosage of 8 μg/kg/day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism. Eur J Pediatr 1997:156:94-98.
13. Rovet JF, Ehrlich RM: Long-term effects of L-thyroxine therapy of congenital hypothyroidism. J Pediatr 1995;126:380-386.
14. Heyerdahl S, Kase BF: Significance of elevated serum thyrotropin during treatment of congenital hypothyroidism. Acta Paediatr 1995;84:634-638.
15. 4 therapy for congenital hypothyroidism: Differences between athyreosis vs ectopia and delayed vs normal bone age. J Pediatr Endocrinol Metab 2000;13:63-69.
16. Corcoran JM, Eastman CJ, Carter JN, Lazarus L: Circulating thyroid hormone levels in children. Arch Dis Child 1977;52:716-720.
17. Brock Jacobsen B, Hummer L: Changes in serum concentrations of thyroid hormones and thyroid hormone-binding proteins during early infancy. Acta Paediatr Scand 1979;68:411-418.
18. 3 and TSH concentrations in cord blood and serum of infants up to 3 months of age. Early Hum Dev 1979;3:239-244.
19. Fisher DA: Physiological variations in thyroid hormones: Physiological and pathophysiological considerations. Clin Chem 1996;42:35-39.
20. Germak JA, Foley TP: Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1990;117:211-219.
21. Nelson JC, Clark SJ, Borut DL, Tomei RT, Carlton EI: Age-related changes in serum free thyroxine during childhood and adolescence. J Pediatr 1993;123:899-905.
22. Desai M, Irani AJ, Pandya CS: The importance of reverse tri-iodothyronine in hypothyroid children on replacement treatment. Arch Dis Child 1984;59:30.
23. Hanukoglu A, Perlman K, Shamis I, Bryjnac L, Rovet J, Daneman D: Relationship of etiology to treatment in congenital hypothyroidism. J Clin Endocrinol Metab 2001;86:186-191.
24. New England Congenital Hypothyroidism Collaborative: Correlation of cognitive test scores and adequacy of treatment in adolescents with congenital hypothyroidism. J Pediatr 1994;124:383-387.
25. Schultz RM, Glassman MS, MacGillivray MH: Elevated threshold for thyrotropin suppression in congenital hypothyroidism. Am J Dis Child 1980;134:19-20.
26. Fisher DA, Schoen EJ, La Franchi S, Mandel SH, Nelson JC, Carlton EI, Goshi JH: The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism. J Clin Endocrinol Metab 2000;85:2722-2727.
27. Escobar-Morreale HF, del Rey FE, Obrejon MJ, de Escobar GM: Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomised rat. Endocrinology 1996;137:2490-2502.
28. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr: Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424-429.
29. Silva JE: Pituitary-thyroid relationships in hypothyroidism. Baillières Clin Endocrinol Metab 1988;2:541-565.
30. Toft AD: Thyroid hormone replacement - one hormone or two? N Engl J Med 1999;340:469-470.